IFNAR1 and Zika virus infectious disease: Intradermal electroporation of as little as 1 μg of this vaccine elicited potent humoral and cellular immune responses in BALB/c and IFNAR−/− C57BL/6 mice, resulting in complete protection of the latter mice against ZIKV infection.